Peer-reviewed veterinary case report
Platelet-rich plasma use for osteoarthritis treatment in dogs
By Carr, Brittany J et al.·Published in Journal of the American Veterinary Medical Association·2024·The Veterinary Sports Medicine and Rehabilitation Center·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Literature review details and supports the application of platelet-rich plasma products in canine medicine, particularly as an orthobiologic agent for osteoarthritis.
- Species:
- dog
Plain-English summary
A review of platelet-rich plasma (PRP) treatments shows that this therapy can help dogs with osteoarthritis, a common joint problem that causes pain and stiffness. PRP is made from the dog's own blood and is safe, affordable, and easy to apply directly to the affected area. It contains growth factors that may help reduce inflammation and promote healing in the joints. Many veterinarians are now considering PRP as a viable option for managing osteoarthritis in dogs, thanks to its potential benefits supported by clinical studies.
People also search for: dog osteoarthritis treatment · platelet-rich plasma for dogs · how to help my dog with joint pain
Abstract
Platelet-rich plasma (PRP) and other platelet-derived products represent a subset of regenerative medicine and have been researched in the veterinary community for the treatment of osteoarthritis, soft tissue wounds, tendinopathies, periodontitis, and fracture repairs. PRP is simple to produce, relatively affordable, safe, and can be delivered on site, making it an appealing therapeutic agent in veterinary medicine. As an orthobiologic for the treatment of osteoarthritis, it is one of few interventions with clinical study support that possess anabolic potential. Platelet product variability is wide ranging and often described in terms of cellular content or platelet enrichment. Growth factors associated with platelet activation and subsequent degranulation may mediate inflammation, modulate cellular immune response, and promote tissue repair. Product composition, dosage, and application likely influence treatment outcomes depending on the classification of the disease targeted. Sufficient canine data regarding the formulation and clinical application of canine PRP exist to warrant review. The aim of this narrative is to provide scientific background and clinical insight for veterinarians regarding platelet product content/formulation, mechanisms of action, considerations for use, and clinical application in dogs.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/38382202/